These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23781294)

  • 1. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.
    Vinchi F; Tolosano E
    Oxid Med Cell Longev; 2013; 2013():396527. PubMed ID: 23781294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.
    Frimat M; Boudhabhay I; Roumenina LT
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31766155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.
    Vinchi F; De Franceschi L; Ghigo A; Townes T; Cimino J; Silengo L; Hirsch E; Altruda F; Tolosano E
    Circulation; 2013 Mar; 127(12):1317-29. PubMed ID: 23446829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload.
    Vinchi F; Gastaldi S; Silengo L; Altruda F; Tolosano E
    Am J Pathol; 2008 Jul; 173(1):289-99. PubMed ID: 18556779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.
    Graw JA; Yu B; Rezoagli E; Warren HS; Buys ES; Bloch DB; Zapol WM
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1120-H1127. PubMed ID: 28314763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.
    Ingoglia G; Sag CM; Rex N; De Franceschi L; Vinchi F; Cimino J; Petrillo S; Wagner S; Kreitmeier K; Silengo L; Altruda F; Maier LS; Hirsch E; Ghigo A; Tolosano E
    Free Radic Biol Med; 2017 Jul; 108():452-464. PubMed ID: 28400318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
    Gbotosho OT; Kapetanaki MG; Kato GJ
    Front Immunol; 2020; 11():561917. PubMed ID: 33584641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron.
    Pires IS; Berthiaume F; Palmer AF
    Annu Rev Biomed Eng; 2023 Jun; 25():1-21. PubMed ID: 37289555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
    Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E
    Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
    Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cells, hemoglobin, heme, iron, and atherogenesis.
    Nagy E; Eaton JW; Jeney V; Soares MP; Varga Z; Galajda Z; Szentmiklósi J; Méhes G; Csonka T; Smith A; Vercellotti GM; Balla G; Balla J
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1347-53. PubMed ID: 20378845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias.
    Jeffers A; Gladwin MT; Kim-Shapiro DB
    Free Radic Biol Med; 2006 Nov; 41(10):1557-65. PubMed ID: 17045924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease.
    Bashi A; Lekpor C; Hood JL; Thompson WE; Stiles JK; Driss A
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis.
    Merle NS; Grunenwald A; Figueres ML; Chauvet S; Daugan M; Knockaert S; Robe-Rybkine T; Noe R; May O; Frimat M; Brinkman N; Gentinetta T; Miescher S; Houillier P; Legros V; Gonnet F; Blanc-Brude OP; Rabant M; Daniel R; Dimitrov JD; Roumenina LT
    Front Immunol; 2018; 9():179. PubMed ID: 29545789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion.
    Donadee C; Raat NJ; Kanias T; Tejero J; Lee JS; Kelley EE; Zhao X; Liu C; Reynolds H; Azarov I; Frizzell S; Meyer EM; Donnenberg AD; Qu L; Triulzi D; Kim-Shapiro DB; Gladwin MT
    Circulation; 2011 Jul; 124(4):465-76. PubMed ID: 21747051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis.
    Tolosano E; Fagoonee S; Hirsch E; Berger FG; Baumann H; Silengo L; Altruda F
    Blood; 2002 Dec; 100(12):4201-8. PubMed ID: 12393471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics.
    Buzzi RM; Owczarek CM; Akeret K; Tester A; Pereira N; Butcher R; Brügger-Verdon V; Hardy MP; Illi M; Wassmer A; Vallelian F; Humar R; Hugelshofer M; Buehler PW; Gentinetta T; Schaer DJ
    Mol Pharm; 2021 Aug; 18(8):3158-3170. PubMed ID: 34292741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics.
    Vallelian F; Buehler PW; Schaer DJ
    Blood; 2022 Oct; 140(17):1837-1844. PubMed ID: 35660854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemopexin: a review of biological aspects and the role in laboratory medicine.
    Delanghe JR; Langlois MR
    Clin Chim Acta; 2001 Oct; 312(1-2):13-23. PubMed ID: 11580905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasculopathy and pulmonary hypertension in sickle cell disease.
    Potoka KP; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.